Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Shenzhen
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Guizhou Xinbang Pharmaceutical Co Ltd

+ Add to Watchlist

002390:CH

22.050 CNY 0.150 0.68%

As of 03:00:27 ET on 05/29/2015.

Snapshot for Guizhou Xinbang Pharmaceutical Co Ltd (002390)

Open: 21.700 Day's Range: 19.780 - 22.970 Volume: 39,356,851
Previous Close: 21.900 52wk Range: 6.680 - 25.160 1-Yr Rtn: +172.20%

Stock Chart for 002390

No chart data available.
  • 002390:CH 22.050
  • 1D
  • 1M
  • 1Y
21.900
Interactive 002390 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 002390

Current P/E Ratio (ttm) 142.5155
Estimated P/E(12/2015) 126.0000
Relative P/E vs. SZASHR 2.0607
Earnings Per Share (CNY) (ttm) 0.1547
Est. EPS (CNY) (12/2015) 0.1750
Est. PEG Ratio -
Market Cap (M CNY) 27,587.56
Shares Outstanding (M) 1,251.14
30 Day Average Volume 27,358,390
Price/Book (mrq) 11.3531
Price/Sale (ttm) 8.0012
Dividend Indicated Gross Yield 0.11%
Cash Dividend (CNY) 0.0240
Dividend Ex-Date 05/25/2015
5 Year Dividend Growth -
Next Earnings Announcement 08/26/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 002390

  • Revenue
  • Net Income (M/CNY)
  • Profit Margin (%)

Company Profile & Key Executives for 002390

Guizhou Xinbang Pharmaceutical Co., Ltd. has operations in Chinese herbal plant plantation, drug development, pharmaceutical production and sales. The Company's products include cerebral vascular pharmaceuticals and digestion related pharmaceuticals.

Zhang GuanfuChairman/PresidentDu JianVice Chairman
Liu XiaoyangVP/Chief EngineerWang PiminVice President
More Company Profile & Key Executives for 002390

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil